The cardiac-specific n-terminal region of troponin I positions the regulatory domain of troponin C

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 40, 2014, Pages 14412-14417

  Hwang, Peter M ^a   Cai, Fangze ^a   Pineda Sanabria, Sandra E ^a   Corson, David C ^a   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dilated cardiomyopathy; Fuzzy complex; Heart failure; Hypertrophic cardiomyopathy; Post translational modification

Indexed keywords

CALCIUM; PEPTIDE FRAGMENT; PROTEIN BINDING; SERINE; TROPONIN C; TROPONIN I;

BINDING COMPETITION; CARDIAC MUSCLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE; PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SPECTROFLUOROMETRY; STATIC ELECTRICITY;

BINDING, COMPETITIVE; CALCIUM; HUMANS; MODELS, MOLECULAR; MUTATION; MYOCARDIUM; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERINE; SPECTROMETRY, FLUORESCENCE; STATIC ELECTRICITY; TROPONIN C; TROPONIN I;

EID: 84907689207     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1410775111     Document Type: Article

References (52)

1. Sharma K, Kass DA (2014) Heart failure with preserved ejection fraction: Mechanisms, clinical features, and therapies. Circ Res 115(1):79-96.
2. Solaro RJ, Moir AJ, Perry SV (1976) Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature 262(5569):615-617.
3. van der Velden J (2011) Diastolic myofilament dysfunction in the failing human heart. Pflugers Arch 462(1):155-163.
4. Solaro RJ, van der Velden J (2010) Why does troponin I have so many phosphorylation sites? Fact and fancy. J Mol Cell Cardiol 48(5):810-816.
5. Zhang J, et al. (2011) Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J Proteome Res 10(9):4054-4065.
6. Solaro RJ, Henze M, Kobayashi T (2013) Integration of troponin I phosphorylation with cardiac regulatory networks. Circ Res 112(2):355-366.
7. Wattanapermpool J, Guo X, Solaro RJ (1995) The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 27(7):1383-1391.
8. Hamdani N, et al. (2009) Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. Eur Heart J 30(15): 1863-1872.
9. Hanft LM, Biesiadecki BJ, McDonald KS (2013) Length dependence of striated muscle force generation is controlled by phosphorylation of cTnI at serines 23/24. J Physiol 591(Pt 18):4535-4547.
10. Wijnker PJ, et al. (2014) Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation. Am J Physiol Heart Circ Physiol 306(8):H1171-H1181.
11. Henze M, et al. (2013) New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I. Biochim Biophys Acta 1833(4):823-832.
12. Hinken AC, et al. (2012) Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A. J Muscle Res Cell Motil 33(6):439-448.
13. van der Velden J, et al. (2006) Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. Cardiovasc Res 69(4):876-887.
14. 2? sensitivity. Cardiovasc Res 99(1): 65-73.
15. Takeda S, Yamashita A, Maeda K, Maéda Y (2003) Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 424(6944):35-41.
16. Howarth JW, Meller J, Solaro RJ, Trewhella J, Rosevear PR (2007) Phosphorylationdependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. J Mol Biol 373(3):706-722.
17. Ward DG, et al. (2004) Characterization of the interaction between the N-terminal extension of human cardiac troponin I and troponin C. Biochemistry 43(13): 4020-4027.
18. Ferrières G, et al. (2000) Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- And C-terminal low affinity contributing regions. FEBS Lett 479(3):99-105.
19. Biesiadecki BJ, et al. (2010) Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice. J Biol Chem 285(25):19688-19698.
20. Camilloni C, De Simone A, Vranken WF, Vendruscolo M (2012) Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry 51(11):2224-2231.
21. Cheung MS, Maguire ML, Stevens TJ, Broadhurst RW (2010) DANGLE: A Bayesian inferential method for predicting protein backbone dihedral angles and secondary structure. J Magn Reson 202(2):223-233.
22. Shen Y, Bax A (2012) Identification of helix capping and b-turn motifs from NMR chemical shifts. J Biomol NMR 52(3):211-232.
23. Baryshnikova OK, Li MX, Sykes BD (2008) Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: Influence of PKA phosphorylation and involvement in cardiomyopathies. J Mol Biol 375(3):735-751.
24. Ward DG, Cornes MP, Trayer IP (2002) Structural consequences of cardiac troponin I phosphorylation. J Biol Chem 277(44):41795-41801.
25. Fuxreiter M(2012) Fuzziness: Linking regulation to protein dynamics. Mol Biosyst 8(1): 168-177.
26. Mittag T, et al. (2008) Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci USA 105(46):17772-17777.
27. Bozoky Z, et al. (2013) Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- And intermolecular interactions. Proc Natl Acad Sci USA 110(47):E4427-E4436.
28. Finley N, et al. (1999) NMR analysis of cardiac troponin C-troponin I complexes: Effects of phosphorylation. FEBS Lett 453(1-2):107-112.
29. Sia SK, et al. (1997) Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem 272(29):18216-18221.
30. Eichmüller C, Skrynnikov NR (2005) A new amide proton R1rho experiment permits accurate characterization of microsecond time-scale conformational exchange. J Biomol NMR 32(4):281-293.
31. Li MX, Spyracopoulos L, Sykes BD (1999) Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. Biochemistry 38(26):8289-8298.
32. Davis JP, et al. (2007) Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys J 92(9):3195-3206.
33. Wijnker PJ, et al. (2014) Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes. Arch Biochem Biophys 554:11-21.
34. Carballo S, et al. (2009) Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 105(4):375-382.
35. Gaponenko V, et al. (1999) Effects of troponin I phosphorylation on conformational exchange in the regulatory domain of cardiac troponin C. J Biol Chem 274(24): 16681-16684.
36. Iakoucheva LM, et al. (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32(3):1037-1049.
37. Tang X, et al. (2012) Composite low affinity interactions dictate recognition of the cyclin-dependent kinase inhibitor Sic1 by the SCFCdc4 ubiquitin ligase. Proc Natl Acad Sci USA 109(9):3287-3292.
38. Ward DG, et al. (2004) NMR and mutagenesis studies on the phosphorylation region of human cardiac troponin I. Biochemistry 43(19):5772-5781.
39. Arad M, et al. (2005) Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112(18):2805-2811.
40. Gomes AV, Harada K, Potter JD (2005) A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol 39(5): 754-765.
41. Wang Y, et al. (2012) Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy. J Biol Chem 287(3):2156-2167.
42. Tripet B, Van Eyk JE, Hodges RS (1997) Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2+-dependent regulation of muscle contraction. J Mol Biol 271(5): 728-750.
43. Farman GP, et al. (2011) Myosin head orientation: A structural determinant for the Frank-Starling relationship. Am J Physiol Heart Circ Physiol 300(6):H2155-H2160.
44. Mateja RD, de Tombe PP (2012) Myofilament length-dependent activation develops within 5 ms in guinea-pig myocardium. Biophys J 103(1):L13-L15.
45. Li MX, et al. (2002) Kinetic studies of calcium and cardiac troponin I peptide binding to human cardiac troponin C using NMR spectroscopy. Eur Biophys J 31(4):245-256.
46. Wang X, Mercier P, Letourneau PJ, Sykes BD (2005) Effects of Phe-to-Trp mutation and fluorotryptophan incorporation on the solution structure of cardiac troponin C, and analysis of its suitability as a potential probe for in situ NMR studies. Protein Sci 14(9):2447-2460.
47. Hwang PM, Pan JS, Sykes BD (2012) A PagP fusion protein system for the expression of intrinsically disordered proteins in Escherichia coli. Protein Expr Purif 85(1):148-151.
48. Baryshnikova OK, Williams TC, Sykes BD (2008) Internal pH indicators for biomolecular NMR. J Biomol NMR 41(1):5-7.
49. Boucher W, Laue ED, Campbell-Burk S, Domaille PJ (1992) Four-dimensional heteronuclear triple resonance NMR methods for the assignment of backbone nuclei in proteins. J Am Chem Soc 114(6):2262-2264.
50. Delaglio F, et al. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6(3):277-293.
51. Johnson BA, Blevins RA (1994) NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR 4(5):603-614.
52. Lipari G, Szabo A (1982) Model-free approach to the interpretation of nuclear macnetic resonance relaxation in macromolecules. 1. Theory and range of validity. J Am Chem Soc 104(17):4546-4559.